
Sign up to save your podcasts
Or
In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.
4.8
129129 ratings
In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.
129 Listeners
285 Listeners
318 Listeners
36 Listeners
485 Listeners
14 Listeners
87 Listeners
22 Listeners
179 Listeners
342 Listeners
509 Listeners
321 Listeners
178 Listeners
362 Listeners
78 Listeners